Although Randomized Controlled Trials Support the Evidence Base for the Several Different Measures to Prevent or Manage Xerostomia Following Cancer Treatment, Intensity-Modified Radiotherapy (IMRT) Should be Used When Possible

Rogers, Simon N (2010) Although Randomized Controlled Trials Support the Evidence Base for the Several Different Measures to Prevent or Manage Xerostomia Following Cancer Treatment, Intensity-Modified Radiotherapy (IMRT) Should be Used When Possible. Journal of Evidence-Based Dental Practice, 10 (3). pp. 147-149. ISSN 1532-3382 DOI https://doi.org/10.1016/j.jebdp.2010.06.005

Item not available from this archive.

Abstract

Article Title and Bibliographic Information A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, et al. Support Care Cancer. 2010 Mar 25. [Epub ahead of print.] Reviewer Simon N. Rogers, FDS, RCS, FRCS, MD Purpose/Question What is the evidence in support of different management strategies for salivary gland hypofunction and xerostomia caused by cancer treatments? Source of Funding Information not available Type of Study/Design Systematic review Level of Evidence Level 1: Good-quality, patient-oriented evidence Strength of Recommendation Grade Grade A: Consistent, good-quality patient-oriented evidence

Item Type: Article
Subjects: R Medicine > RT Nursing
Divisions: Nursing and Midwifery
Date Deposited: 16 Apr 2012 14:17
URI: http://repository.edgehill.ac.uk/id/eprint/3828

Archive staff only

Item control page Item control page